Rapamycin augments the NMDA-mediated TNF suppression of MRSA-stimulated RAW264.7 murine macrophages

International Journal of Inflammation

Volumn 2012, Issue , 2012, Pages

  Spentzas, Thomas ^a,b,c   Shappley, Rebekah K H ^a   Savorgnan, Fabio ^a   Meals, Elizabeth ^a,c   English, B Keith ^a,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

^c LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 2 MORPHOLINO 8 PHENYLCHROMONE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID; RAPAMYCIN; TUMOR NECROSIS FACTOR; VANCOMYCIN;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CELL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; ENZYME REPRESSION; MACROPHAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TREATMENT RESPONSE;

EID: 84876511765     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2012/542727     Document Type: Article

References (52)

1. Moran G. J., Krishnadasan A., Gorwitz R. J., Fosheim G. E., McDougal L. K., Carey R. B., Talan D. A., Methicillin-resistant S. aureus infections among patients in the emergency department. The New England Journal of Medicine 2006 355 7 666 674 2-s2.0-33747343208 10.1056/NEJMoa055356
2. Watson R. S., Carcillo J. A., Linde-Zwirble W. T., Clermont G., Lidicker J., Angus D. C., The epidemiology of severe sepsis in children in the United States. American Journal of Respiratory and Critical Care Medicine 2003 167 5 695 701 2-s2.0-0037364655 10.1164/rccm.200207-682OC (Pubitemid 36801744)
3. van Amersfoort E. S., van Berkel T. J. C., Kuiper J., Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clinical Microbiology Reviews 2003 16 3 379 414 2-s2.0-0038447123 10.1128/CMR.16.3.379-414.2003 (Pubitemid 36871313)
4. Chawla-Sarkar M., Lindner D. J., Liu Y. F., Williams B. R., Sen G. C., Silverman R. H., Borden E. C., Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003 8 3 237 249 2-s2.0-0037790592 10.1023/A:1023668705040 (Pubitemid 36749609)
5. Idvall J., Ahlgren I., Aronsen K. F., Stenberg P., Ketamine infusions: pharmacokinetics and clinical effects. British Journal of Anaesthesia 1979 51 12 1167 1173 2-s2.0-0018631363 (Pubitemid 10171522)
6. Beutler B., Cerami A., Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annual Review of Biochemistry 1988 57 505 518 2-s2.0-0023944339
7. Tartaglia L. A., Goeddel D. V., Two TNF receptors. Immunology Today 1992 13 5 151 153 2-s2.0-0026514526
8. Vandenabeele P., Declerq W., Beyaert R., Fiers W., Two tumour necrosis factor receptors: structure and function. Trends in Cell Biology 1995 5 10 392 399 2-s2.0-0029114596 10.1016/S0962-8924(00)89088-1
9. Spentzas T., Kudumula R., Acuna C., Talati A. J., Ingram K. C., Savorgnan F., Meals E. A., English B. K., Role of bacterial components in macrophage activation by the LAC and MW2 strains of community-associated, methicillin-resistant Staphylococcus aureus. Cellular Immunology 2011 269 1 46 53 2-s2.0-79955470925 10.1016/j.cellimm.2011.03.009
10. English B. K., Maryniw E. M., Talati A. J., Meals E. A., Diminished macrophage inflammatory response to Staphylococcus aureus isolates exposed to daptomycin versus vancomycin or oxacillin. Antimicrobial Agents and Chemotherapy 2006 50 6 2225 2227 2-s2.0-33744493113 10.1128/AAC.01559-05 (Pubitemid 43807550)
11. Spentzas T., Shapley R. K. H., Aguirre C. A., Meals E., Lazar L., Rayburn M. S., Walker B. S., English B. K., Ketamine inhibits tumor necrosis factor secretion by RAW264.7 murine macrophages stimulated with antibiotic-exposed strains of community-associated, methicillin-resistant Staphylococcus aureus. BMC Immunology 2011 12, article 11 2-s2.0-78951478260 10.1186/1471-2172-12-11
12. Reddy S. A., Huang J. H., Liao W. S., Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF- κ B activation. Journal of Immunology 2000 164 3 1355 1363 (Pubitemid 30067249)
13. Li N., Lee B., Liu R. J., Banasr M., Dwyer J. M., Iwata M., Li X. Y., Aghajanian G., Duman R. S., mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010 329 5994 959 964 2-s2.0-77955909841 10.1126/science.1190287
14. Lu Y. F., Tomizawa K., Moriwaki A., Hayashi Y., Tokuda M., Itano T., Hatase O., Matsui H., Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation in the rat hippocampus. Brain Research 1996 729 1 142 146 2-s2.0-0030570717 10.1016/S0006-8993(96)00568-9 (Pubitemid 26276191)
15. Sehgal S. N., Baker H., Vezina C., Rapamycin (AY 22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. Journal of Antibiotics 1975 28 10 727 732 2-s2.0-0016713286
16. Bottino R., Fernandez L. A., Ricordi C., Lehmann R., Tsan M. F., Oliver R., Inverardi L., Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998 47 3 316 323 2-s2.0-0031890972 10.2337/diabetes.47.3. 316 (Pubitemid 28104190)
17. Hartner W. C., van der Werf W. J., Lodge J. P. A., Gilchrist B., de Fazio S. R., Markees T. G., Yatko C., Monaco A. P., Gozzo J. J., Effect of rapamycin on renal allograft survival in canine recipients treated with antilymphocyte serum, donor bone marrow, and cyclosporine. Transplantation 1995 60 11 1347 1350 2-s2.0-0029587330 (Pubitemid 26005294)
18. Kahan B. D., Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Lancet 2000 356 9225 194 202 2-s2.0-0034661736 (Pubitemid 30446974)
19. Kahan B. D., Julian B. A., Pescovitz M. D., Vanrenterghem Y., Neylan J., Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Transplantation 1999 68 10 1526 1532 2-s2.0-0033610638
20. Sacks S. H., Rapamycin on trial. Nephrology Dialysis Transplantation 1999 14 9 2087 2089 2-s2.0-0032773246 10.1093/ndt/14.9.2087 (Pubitemid 29403395)
21. Sigrist S., Ebel N., Langlois A., Bosco D., Toso C., Kleiss C., Mandes K., Berney T., Pinget M., Belcourt A., Kessler L., Role of chemokine signaling pathways in pancreatic islet rejection during allo- and xenotransplantation. Transplantation Proceedings 2005 37 8 3516 3518 2-s2.0-27844561126 10.1016/j.transproceed.2005.09.048 (Pubitemid 41659939)
22. Pritchard D. I., Sourcing a chemical succession for cyclosporin from parasites and human pathogens. Drug Discovery Today 2005 10 10 688 691 2-s2.0-19444363444 10.1016/S1359-6446(05)03395-7 (Pubitemid 40724550)
23. McKeon F., When worlds collide: immunosuppresants meet protein phosphatases. Cell 1991 66 5 823 826 2-s2.0-0025925274 10.1016/0092-8674(91) 90426-Y (Pubitemid 121001716)
24. Wang T., Donahoe P. K., Zervos A. S., Specific interaction of type I receptors of the TGF- β family with the immunophilin FKBP-12. Science 1994 265 5172 674 676 2-s2.0-0028108801 (Pubitemid 24268280)
25. Brown E. J., Albers M. W., Shin T. B., Ichikawa K., Keith C. T., Lane W. S., Schreiber S. L., A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994 369 6483 756 758 2-s2.0-0028360374 10.1038/369756a0 (Pubitemid 24225367)
26. Moore P. A., Rosen C. A., Carter K. C., Assignment of the human FKBP12-rapamycin-associated protein (FRAP) gene to chromosome 1p36 by fluorescence in situ hybridization. Genomics 1996 33 2 331 332 2-s2.0-0029881595 10.1006/geno.1996.0206 (Pubitemid 26132137)
27. Chung J., Kuo C. J., Crabtree G. R., Blenis J., Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 1992 69 7 1227 1236 2-s2.0-0026659046 10.1016/0092-8674(92)90643-Q
28. Huang S., Bjornsti M. A., Houghton P. J., Rapamycins: mechanism of action and cellular resistance. Cancer Biology and Therapy 2003 2 3 222 232 2-s2.0-0346362997 10.4161/cbt.2.3.360
29. Sabers C. J., Martin M. M., Brunn G. J., Williams J. M., Dumont F. J., Wiederrecht G., Abraham R. T., Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. The Journal of Biological Chemistry 1995 270 2 815 822 2-s2.0-0028950217 10.1074/jbc.270.2.815
30. Hay N., Sonenberg N., Upstream and downstream of mTOR. Genes and Development 2004 18 16 1926 1945 2-s2.0-4043171462 10.1101/gad.1212704 (Pubitemid 39071573)
31. Adkins J. R., Castresana M. R., Wang Z., Newman W. H., Rapamycin inhibits release of tumor necrosis factor- α from human vascular smooth muscle cells. American Surgeon 2004 70 5 384 387 2-s2.0-2542612167
32. Woltman A. M., de Fijter J. W., Kamerling S. W. A., van der Kooij S. W., Paul L. C., Daha M. R., van Kooten C., Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. Blood 2001 98 1 174 180 2-s2.0-0035412393 10.1182/blood.V98.1.174
33. Barilli A., Visigalli R., Sala R., Gazzola G. C., Parolari A., Tremoli E., Bonomini S., Simon A., Closs E. I., Dall'Asta V., Bussolati O., In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function. Cardiovascular Research 2008 78 3 563 571 2-s2.0-44449099566 10.1093/cvr/cvn024 (Pubitemid 351769758)
34. Buckingham S. C., McDougal L. K., Cathey L. D., Comeaux K., Craig A. S., Fridkin S. K., Tenover F. C., Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital. Pediatric Infectious Disease Journal 2004 23 7 619 624 2-s2.0-3142710031 10.1097/01.inf.0000131981.67342.c4 (Pubitemid 38924885)
35. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. Morbidity and Mortality Weekly Report 1999 48 32 707 710
36. Wang R., Braughton K. R., Kretschmer D., Bach T. H. L., Queck S. Y., Li M., Kennedy A. D., Dorward D. W., Klebanoff S. J., Peschel A., DeLeo F. R., Otto M., Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nature Medicine 2007 13 12 1510 1514 2-s2.0-36849049884 10.1038/nm1656 (Pubitemid 350224240)
37. Feng N., Vollenweider F. X., Minder E. I., Rentsch K., Grampp T., Vonderschmitt D. J., Development of a gas chromatography-mass spectrometry method for determination of ketamine in plasma and its application to human samples. Therapeutic Drug Monitoring 1995 17 1 95 100 2-s2.0-0028813093
38. Parkin M. C., Turfus S. C., Smith N. W., Halket J. M., Braithwaite R. A., Elliott S. P., Osselton M. D., Cowan D. A., Kicman A. T., Detection of ketamine and its metabolites in urine by ultra high pressure liquid chromatography- tandem mass spectrometry. Journal of Chromatography B 2008 876 1 137 142 2-s2.0-56249147035 10.1016/j.jchromb.2008.09.036
39. Wieber J., Gugler R., Hengstmann J. H., Dengler H. J., Pharmacokinetics of ketamine in man. Anaesthesist 1975 24 6 260 263 2-s2.0-0016749991
40. Cohen J., Abraham E., Microbiologic findings and correlations with serum tumor necrosis factor- α in patients with severe sepsis and septic shock. Journal of Infectious Diseases 1999 180 1 116 121 2-s2.0-0032977569 10.1086/314839 (Pubitemid 29293925)
41. Kawasaki C., Kawasaki T., Ogata M., Nandate K., Shigematsu A., Ketamine isomers suppress superantigen-induced proinflammatory cytokine production in human whole blood. Canadian Journal of Anesthesia 2001 48 8 819 823 2-s2.0-0034767194 (Pubitemid 33040242)
42. Kawasaki T., Ogata M., Kawasaki C., Ogata J. I., Inoue Y., Shigematsu A., Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesthesia and Analgesia 1999 89 3 665 669 2-s2.0-0032845356 10.1097/00000539-199909000-00024 (Pubitemid 29409817)
43. Koga K., Ogata M., Takenaka I., Matsumoto T., Shigematsu A., Ketamine suppresses tumor necrosis factor- α activity and mortality in carrageenan-sensitized endotoxin shock model. Circulatory Shock 1994 44 3 160 168 2-s2.0-0028630784
44. Girardin E., Dayer J. M., Cytokines and antagonists in septic shock. Schweizerische Medizinische Wochenschrift 1993 123 11 480 491 2-s2.0-0027523422 (Pubitemid 23089287)
45. Waage A., Halstensen A., Espevik T., Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. The Lancet 1987 1 8529 355 357 2-s2.0-0023094408 (Pubitemid 17010024)
46. Offner F., Philippe J., Vogelaers D., Colardyn F., Baele G., Baudrihaye M., Vermeulen A., Leroux-Roels G., Serum tumor necrosis factor levels in patients with infectious disease and septic shock. Journal of Laboratory and Clinical Medicine 1990 116 1 100 105 2-s2.0-0025146201 (Pubitemid 20250753)
47. Calandra T., Baumgartner J. D., Grau G. E., Wu M. M., Lambert P. H., Schellekens J., Verhoef J., Glauser M. P., Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon- α and interferon- γ in the serum of patients with septic shock. Journal of Infectious Diseases 1990 161 5 982 987 2-s2.0-0025266645 (Pubitemid 20148336)
48. Riche F., Panis Y., Laisne M. J., Briard C., Cholley B., Bernard-Poenaru O., Graulet A. M., Gueris J., Valleur P., High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients. Surgery 1996 120 5 801 807 2-s2.0-0029998575 10.1016/S0039-6060(96)80087-0 (Pubitemid 26378180)
49. Shah O. J., Wang Z., Hunter T., Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Current Biology 2004 14 18 1650 1656 2-s2.0-4544343980 10.1016/j.cub.2004.08.026 (Pubitemid 39239362)
50. Manning B. D., Logsdon M. N., Lipovsky A. I., Abbott D., Kwiatkowski D. J., Cantley L. C., Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes and Development 2005 19 15 1773 1778 2-s2.0-23744516268 10.1101/gad.1314605 (Pubitemid 41126916)
51. Guertin D. A., Sabatini D. M., An expanding role for mTOR in cancer. Trends in Molecular Medicine 2005 11 8 353 361 2-s2.0-23144467910 10.1016/j.molmed.2005.06.007 (Pubitemid 41080576)
52. Sarbassov D. D., Ali S. M., Sengupta S., Sheen J. H., Hsu P. P., Bagley A. F., Markhard A. L., Sabatini D. M., Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Molecular Cell 2006 22 2 159 168 2-s2.0-33646023695 10.1016/j.molcel.2006.03.029